ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Atorvastatin

Also written as “atorvastatin”, “Atorvastatin 20 mg” and “Comparator: atorvastatin”.

Its studies are mostly in Hypercholesterolemia · Dyslipidemias · Hyperlipidemias · Diabetes Mellitus, Type 2 · Cardiovascular Diseases, led by 22 companies.

Drug pageAtorvastatin: every studyMany companies study it; this page follows only the 105 they lead. All 640 studies, academic ones too, with its approvals and label.
Furthest: phase 4, since Aug 30, 2005105 company-led studies, 1 open or runningNext primary completion: Apr 2027 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Viatris290 open or runningphase 4since Aug 30, 2005Aug 25, 2005none ahead
Organonits history only200 open or runningphase 4since Apr 1, 2008Sep 23, 2004none ahead
Pfizerits history only160 open or runningphase 4since Sep 6, 2005Aug 22, 2005none ahead
Chong Kun Dang Pharmaceuticalits history only60 open or runningphase 4since Nov 16, 2009Nov 16, 2009none ahead
Dr. Reddy's Laboratoriesits history only60 open or runningphase 1since Jul 18, 2012Jul 18, 2012none ahead
GlaxoSmithKlineits history only60 open or runningphase 3since Dec 15, 2011Dec 11, 2006none ahead
Astellas Pharmaits history only30 open or runningphase 4since Dec 5, 2006Dec 5, 2006none ahead
Daiichi Sankyoits history only30 open or runningphase 4since Sep 16, 2008Sep 16, 2008none ahead
Midas Pharmaits history only20 open or runningphase 1since Jan 23, 2020Jan 23, 2020none ahead
Sun Pharmaceutical Industriesits history only20 open or runningphase 1since Dec 20, 2011Dec 20, 2011none ahead

Also a collaborator on its studies: Parexel, Pharma Medica Research, Merck, Regeneron Pharmaceuticals, MDS Pharma Services, Celerion, Sanofi and Basilea Pharmaceutica International.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Viatris only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 5 studies since Aug 25, 2005.

  1. Sep 6, 20055 phase 4 studiesNCT00150384, NCT00159718, NCT00174330 and 2 more
  2. Feb 28, 2006Phase 3 study in HypertensionNCT00330785 · 1,250 enrolled · Canada, United Kingdom
  3. Jun 20, 2006Phase 3 study in Cardiovascular DiseasesNCT00343655 · 160 enrolled · United States
  4. Feb 28, 20072 phase 4 studies in Coronary Artery DiseaseNCT00442845, NCT00442325
  5. Apr 4, 2007Phase 4 study in Arrhythmias, CardiacNCT00457340 · 220 enrolled · Belgium, Greece
  6. Oct 4, 2007Phase 4 study in DyslipidemiasNCT00540293 · 425 enrolled · Korea, Republic of
  7. Mar 14, 20086 phase 4 studiesNCT00640549, NCT00645424, NCT00644670 and 3 more
  8. Jul 31, 2008Phase 4 study in Acute Coronary SyndromeNCT00728988 · 499 enrolled · China, Korea, Republic of
  9. Aug 21, 2008Phase 1 study in Pediatric Heterozygous HypercholesterolemiaNCT00739999 · 39 enrolled · Canada, Greece, Norway
  10. Sep 22, 2008Phase 1 study in HypercholesterolemiaNCT00758004 · 76 enrolled · United States
  11. Jan 21, 2009Phase 3 study in Hyperlipoproteinemia Type IINCT00827606 · 272 enrolled · United States, Belgium, Canada and more
  12. Feb 13, 2009Phase 4 study in HypercholesterolemiaNCT00844376 · 12 enrolled · United States
  13. Jun 8, 2009Phase 4 study in HypercholesterolemiaNCT00917579 · 76 enrolled · United States
  14. Oct 14, 2013Phase 3 study in HypercholesterolemiaNCT01964326 · 1,311 enrolled · United States

TargetBeta

HMGCR →read by rule
“HMG-CoA reductase inhibitor”ChEMBL 37, by rule

Other programs on HMGCR

ProgramCompanyFurthest phaseStudies
rosuvastatinruleAstraZenecaphase 4184
SimvastatinruleOrganonphase 4100
pitavastatinruleKowaphase 436

Studies

All 29 Viatris leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT01964326Hypercholesterolemia · United States3CompletedDec 20141,311
NCT00917579Hypercholesterolemia · United States4CompletedSep 200876
NCT00844376Hypercholesterolemia · United States4CompletedMar 200812
NCT00827606Hyperlipoproteinemia Type II · United States, Belgium, Canada and more3CompletedOct 2013272
NCT00758004Hypercholesterolemia · United States1CompletedMar 200976
NCT00739999Pediatric Heterozygous Hypercholesterolemia · Canada, Greece, Norway1CompletedMay 200939
NCT00728988Acute Coronary Syndrome · China, Korea, Republic of4CompletedApr 2010499
NCT00647543Dyslipidemias · Thailand4Completed242
NCT00645151Dyslipidemias · Brazil, Chile, Colombia and more4Completed512
NCT00644709Dyslipidemias · Belgium4Completed196
NCT00645424Hyperlipidemias · Taiwan4Completed155
NCT00644670Dyslipidemias · Belgium4Completed232
NCT00640549Hyperlipidemias · Germany4Terminated41
NCT00540293Dyslipidemias · Korea, Republic of4CompletedMay 2008425
NCT00457340Arrhythmias, Cardiac · Belgium, Greece4Completed220
NCT00442845Coronary Artery Disease · Cameroon, Canada, Italy and more4CompletedFeb 20042,080
NCT00442325Coronary Artery Disease · Greece, Hungary, Ireland and more4Completed595
NCT00343655Cardiovascular Diseases · United States3Terminated160
NCT00330785Hypertension · Canada, United Kingdom3Completed1,250
NCT00174330Hypertension · China4Completed330
NCT00163202Coronary Artery Disease · Canada, Czechia, France and more4Completed330
NCT00163150Stroke · France4Completed128
NCT00159718Angina Pectoris · Croatia, Czechia, Estonia and more4Completed360
NCT00151502Alzheimer Disease · United States, Australia, Austria and more3Completed600
NCT00150384Hypertension · United States4Completed500
NCT00150371Hypercholesterolemia · Canada3Completed1,100
NCT00141232Diabetes Mellitus, Type 2 · United Kingdom4Completed810
NCT00141141Hypercholesterolemia · Italy4Completed383
NCT00136942Hyperlipidemias · Switzerland3Completed370

How it is read

Names in the registry

  • “Atorvastatin”, 95 entries
  • “atorvastatin”, 36 entries
  • “Atorvastatin 20 mg”, 3 entries
  • “Comparator: atorvastatin”, 3 entries
  • “Atorvastatin 10 mg”, 3 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.